|
Type 2 diabetes
Citations 211-220 of 286 total displayed.
|
Past content
(since Dec 2000):
|
- Scientific Contributions
Sex Differences in Age-Related Stiffening of the Aorta in Subjects With Type 2 Diabetes
- Lorenita De Angelis, Sandrine C. Millasseau, Andrew Smith, GianCarlo Viberti, Richard H. Jones, James M. Ritter, and Philip J. Chowienczyk
Hypertension published May 17, 2004, doi:10.1161/01.HYP.0000130482.81883.fd
[Abstract]
- Editorial Commentaries
When Does New Onset Diabetes Resulting From Antihypertensive Therapy Increase Cardiovascular Risk
- George L. Bakris and James R. Sowers
Hypertension 2004;43:941-942; published online before print as doi:10.1161/01.HYP.0000125727.92964.e2
[Full text]
- Scientific Contributions
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR –Modulating Activity
- Stephen C. Benson, Harrihar A. Pershadsingh, Christopher I. Ho, Amar Chittiboyina, Prashant Desai, Michal Pravenec, Nianning Qi, Jiaming Wang, Mitchell A. Avery, and Theodore W. Kurtz
Hypertension 2004;43:993-1002; published online before print as doi:10.1161/01.HYP.0000123072.34629.57
[Abstract]
[Full text]
- Scientific Contributions
Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice
- Tetsuya Shiuchi, Masaru Iwai, Huan-Sheng Li, Lan Wu, Li-Juan Min, Jian-Mei Li, Midori Okumura, Tai-Xing Cui, and Masatsugu Horiuchi
Hypertension 2004;43:1003-1010; published online before print as doi:10.1161/01.HYP.0000125142.41703.64
[Abstract]
[Full text]
- Scientific Contributions
Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice: A Renoprotective Combination?
- Minghao Ye, Jan Wysocki, Parveen Naaz, Mohammad Reza Salabat, Michael S. LaPointe, and Daniel Batlle
Hypertension 2004;43:1120-1125; published online before print as doi:10.1161/01.HYP.0000126192.27644.76
[Abstract]
[Full text]
- Scientific Contributions
Increased ACE 2 and Decreased ACE Protein in Renal Tubules From Diabetic Mice. A Renoprotective Combination?
- Minghao Ye, Jan Wysocki, Parveen Naaz, Mohammad Reza Salabat, Michael S. LaPointe, and Daniel Batlle
Hypertension published April 12, 2004, doi:10.1161/01.HYP.0000126192.27644.76
[Abstract]
- Letters to the Editor
Is Low-Heat Shock Protein 70 a Primary or a Secondary Event in the Development of Atherosclerosis? • Response: Is Low-Heat Shock Protein 70 a Primary or a Secondary Event in the Development of Atherosclerosis?
- Philip L. Hooper, Joanna J. Hooper, Alan G. Pockley, Anastasia Georgiades, Thomas Thulin, Ulf de Faire, and Johan Frostegård
Hypertension 2004;43:e18-19e; published online before print as doi:10.1161/01.HYP.0000118134.56524.b1
[Full text]
- Editorial Commentary
When Does New Onset Diabetes Resulting From Antihypertensive Therapy Increase Cardiovascular Risk
- George L. Bakris and James R. Sowers
Hypertension published March 22, 2004, doi:10.1161/01.HYP.0000125727.92964.e2
[Abstract]
- Scientific Contributions
Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic Mice
- Tetsuya Shiuchi, Masaru Iwai, Huan-Sheng Li, Lan Wu, Li-Juan Min, Jian-Mei Li, Midori Okumura, Tai-Xing Cui, and Masatsugu Horiuchi
Hypertension published March 22, 2004, doi:10.1161/01.HYP.0000125142.41703.64
[Abstract]
- Scientific Contributions
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPAR-Modulating Activity
- Stephen C. Benson, Harrihar A. Pershadsingh, Christopher I. Ho, Amar Chittiboyina, Prashant Desai, Michal Pravenec, Nianning Qi, Jiaming Wang, Mitchell A. Avery, and Theodore W. Kurtz
Hypertension published March 8, 2004, doi:10.1161/01.HYP.0000123072.34629.57
[Abstract]
|
|
